Business Wire3d
BPGbio to Present Novel Drug Target for Huntington’s Disease and AI Discovered Biomarkers for Alzheimer’s Disease at Society for Neuroscience 2024
BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.
Le Lézard3d
Franchise Awards Announced at TeamLogic IT Annual Convention
TeamLogic IT, a national provider of managed IT services and technology support for small and midsize businesses, recently celebrated the franchise ...
BPGbio’s mitochondrial disorder drug gets paediatric disease status
BPM31510IV is also a lead candidate to treat solid tumours such as glioblastoma multiforme and pancreatic cancer.
Pharmabiz4d
BPGbio receives US FDA rare paediatric disease designation for BPM31510IV for primary coenzyme Q10 deficiency treatment
Boston, Massachusetts Tuesday, October 1, 2024, 14:00 Hrs [IST] ...
BPGbio Receives FDA Rare Pediatric Disease Designation for its Potential Treatment for Primary Coenzyme Q10 Deficiency
BPGbio received an FDA Rare Pediatric Disease Designation for its potential treatment for primary coenzyme Q10 deficiency.
pharmaphorum14d
Changing Faces – Pharma and biotech May and June 2024
Welcome back to another edition of Changing Faces. To get caught up, we’re rounding up all the hires, appointments, and promotions we heard about in the pharma and biotech world in the months of ...
MM&M17d
The Escalator: Imre, Kyverna Therapeutics, The Bloc and more
Kyverna Therapeutics named Warner Biddle as CEO. Trailhead Biosystems hired Joshua Snow as chief commercial officer. BPGbio ...
Le Lézard19d
BPGbio Appoints John Beeler as SVP of Business Development
BPGbio, Inc., a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, today announced the appointment of John Beeler ...
Business Wire19d
BPGbio Appoints John Beeler as SVP of Business Development
BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, today announced the ...